John T Randolph Selected Research

Bilirubin

4/2009

2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John T Randolph Research Topics

Disease

3	Infections 10/2018 - 06/2004
2	Hyperbilirubinemia 04/2009 - 02/2006
1	Neoplasms (Cancer) 01/2023
1	Necrosis 12/2022
1	Contact Dermatitis (Eczema, Contact) 12/2022
1	Lactic Acidosis 04/2010
1	Hyperlipidemias (Hyperlipidemia) 04/2010
1	Insulin Resistance 04/2010
1	HIV Infections (HIV Infection) 01/2004

Drug/Important Bio-Agent (IBA)

3	Protease Inhibitors (Protease Inhibitor)IBA 04/2010 - 01/2004
2	NucleosidesIBA 01/2018 - 04/2010
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	alanylalanine (Ala-Ala)IBA 12/2022
1	Viekira PakIBA 10/2018
1	ombitasvirIBA 10/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	ABT-072IBA 01/2018
1	HIV Protease InhibitorsIBA 04/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2010
1	BilirubinIBA 04/2009
1	amprenavir (Agenerase)FDA Link 02/2006
1	Ritonavir (Norvir)FDA Link 02/2006
1	Indinavir (Crixivan)FDA Link 02/2006
1	Atazanavir Sulfate (Reyataz)FDA Link 02/2006
1	BILN 2061IBA 06/2004
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 06/2004
1	PeptidomimeticsIBA 01/2004

Therapy/Procedure

1	Therapeutics 01/2023
1	Duration of Therapy 10/2018
1	Highly Active Antiretroviral Therapy (HAART) 04/2010